‌

US Patent 11771698 Methods of treating cholangiocarcinoma

Patent 11771698 was granted and assigned to Foundation Medicine on October, 2023 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

Patent attributes

Patent Applicant

Foundation Medicine

Current Assignee

Foundation Medicine

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

Patent Inventor Names

Vincent A. Miller

Jie He

Siraj Mahamed Ali

Jeffrey S. Ross

Doron Lipson

Philip James Stephens

Matthew J. Hawryluk

Date of Patent

October 3, 2023

Patent Application Number

17204830

Date Filed

March 17, 2021

Patent Citations

US Patent 7321029 2′-arabino-fluorooligonucleotide N3′→P5′ phosphoramidates: their synthesis and use

US Patent 7332581 Polypeptide variants with altered effector function

US Patent 7371826 Polypeptide variants with altered effector function

US Patent 7399845 6-modified bicyclic nucleic acid analogs

US Patent 7427672 Artificial nucleic acids of n-o bond crosslinkage type

US Patent 7495088 Modified nucleotide compounds

US Patent 7521541 Cysteine engineered antibodies and conjugates

US Patent 7527791 Humanized anti-TGF-beta antibodies

...

Patent Primary Examiner

Raymond J. Henley, III

CPC Code

Patent abstract

Methods and compositions for treating cholangiocarcinoma.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11771698 Methods of treating cholangiocarcinoma

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.